Cambridge Financial Group Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,048 shares of the healthcare conglomerate’s stock after selling 3,965 shares during the period. UnitedHealth Group makes up 3.5% of Cambridge Financial Group Inc.’s holdings, making the stock its 8th biggest position. Cambridge Financial Group Inc.’s holdings in UnitedHealth Group were worth $6,499,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. BlackRock Inc. grew its holdings in shares of UnitedHealth Group by 1.2% during the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. FMR LLC grew its holdings in shares of UnitedHealth Group by 2.1% during the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of UnitedHealth Group by 2.3% during the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares in the last quarter. Finally, TIAA CREF Investment Management LLC grew its holdings in shares of UnitedHealth Group by 3.9% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after purchasing an additional 223,524 shares in the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

In other news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders sold 62,606 shares of company stock valued at $12,677,525 over the last quarter. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Incorporated (UNH) traded up $2.39 during trading on Wednesday, reaching $224.88. The company’s stock had a trading volume of 1,345,627 shares, compared to its average volume of 3,100,740. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $215,879.17, a P/E ratio of 23.20, a PEG ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a 1 year low of $156.09 and a 1 year high of $231.77.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $2.17 earnings per share. equities research analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were given a $0.75 dividend. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.33%. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

Several analysts recently weighed in on UNH shares. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $225.00 price objective on shares of UnitedHealth Group in a research note on Monday, November 27th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Piper Jaffray Companies raised their price objective on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research note on Tuesday, October 17th. Finally, Morgan Stanley raised their price objective on UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $224.56.

ILLEGAL ACTIVITY WARNING: This news story was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-holdings-trimmed-by-cambridge-financial-group-inc/1761882.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.